China Universal Asset Management Co., Ltd. Astrazeneca PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 148,032 shares of AZN stock, worth $10.9 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
148,032
Previous 149,796
1.18%
Holding current value
$10.9 Million
Previous $9.81 Million
10.86%
% of portfolio
1.04%
Previous 0.95%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...